EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Real-World Evaluation of Demographics, Treatment Pattern, and Economic Burden of Heart Failure and Kidney Disease in Type 2 Diabetes Mellitus Patient Population in Dubai, United Arab Emirates

Alaaeldin Bashier, Mohamed Farghaly, Juwairia Yousif Alali, Amna Khalifa AlHadari, Yasmin Ajaz, Vani Krishna Warrier, Elamin Abdelgadir, Muhammad Hamed Farooqi, Sana Qamar, Mohamed Alsayed, Mohamed Samir Fahmy, Dali Tannouri und 4 weitere

Dubai Diabetes and Endocrinology Journal · 2023 · 29 (1) · 42-54

DOI: 10.1159/000530467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dubai Diabetes and Endocrinology Journal, online erschienen am 26.06.2023. Verfasst von Alaaeldin Bashier und 15 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The current study evaluated the demographics, clinical characteristics, treatment patterns, and economic burden of patients with type 2 diabetes mellitus (T2DM) with comorbidities (heart failure [HF], chronic kidney disease [CKD], and cardiovascular disease [CVD] without HF) in Dubai, United Arab Emirates (UAE).

Methods

This observational, retrospective study collected data from January 01, 2014, to December 31, 2019, from the Dubai Real-World Claims Database (adults ≥18 years; at least 1 T2DM diagnosis claim). Patients were stratified into 5 cohorts: T2DM alone (cohort 1), T2DM and CKD (cohort 2), T2DM and CVD without CKD and HF (cohort 3), T2DM and HF (cohort 4), and T2DM with HF and CKD (cohort 5). An evaluation of demographics and clinical characteristics during pre-index period, as well as treatment patterns, healthcare resource utilization, and costs during the post-index period was conducted.

Results

The sample had 374,271 patients with T2DM (age 43–56 years; male [72–84%]). Patients in cohorts 4 and 5 had Deyo-Charlson Comorbidity Index scores of 4.4 and 5.8, respectively. General practitioners (GPs) routinely prescribed biguanides for patients in cohorts 1–4 (24–38%), and insulin to patients in cohort 5 (27.7%). Prescription rates of novel antihyperglycemic drugs, such as glucagon-like peptide-1 (GLP-1 RA), were very low (∼2–8%) even in cohorts with cardiovascular and renal comorbidities (cohorts 2–5). A similar observation was noted with prescribing rates (0.6–4.4%) of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in cohorts 2–5. Endocrinologists preferred to prescribe GLP-1 RA and SGLT2i to T2DM patients with comorbidities. During the 5-year study period, median outpatient claims were the highest in cohort 5 (8.0 [range, 1.0–168.0]), followed by cohort 2 (5.5 [range, 1.0–52.0]). The median cost for inpatient claims was higher in cohort 5 (16,429 [range, 3,732–29,126] AED) compared to other cohorts. The median cost for drugs and procedures was highest in cohort 5 (4,525 [range, 38–31,546] AED and 2,297 [range, 56–105,074] AED, respectively).

Conclusion

Continued and increased usage of drugs such as SGLT2i and GLP-1 RA with proven cardiorenal benefits could improve long-term outcomes and reduce associated healthcare costs in patients with T2DM and comorbidities in Dubai, UAE.

Zitieren

APA

Bashier, A., Farghaly, M., Alali, J. Y., AlHadari, A. K., Ajaz, Y., Warrier, V. K., Abdelgadir, E., Farooqi, M. H., Qamar, S., Alsayed, M., Fahmy, M. S., Tannouri, D., Gowda, A. J., Awad, N. S., Ramachandrachar, B. C., & Natarajan, A. (2023). Real-World Evaluation of Demographics, Treatment Pattern, and Economic Burden of Heart Failure and Kidney Disease in Type 2 Diabetes Mellitus Patient Population in Dubai, United Arab Emirates. Dubai Diabetes and Endocrinology Journal, 29(1), 42-54. https://doi.org/10.1159/000530467

Vancouver

Bashier A, Farghaly M, Alali JY, AlHadari AK, Ajaz Y, Warrier VK, et al. Real-World Evaluation of Demographics, Treatment Pattern, and Economic Burden of Heart Failure and Kidney Disease in Type 2 Diabetes Mellitus Patient Population in Dubai, United Arab Emirates. Dubai Diabetes and Endocrinology Journal. 2023;29(1):42-54. doi:10.1159/000530467

BibTeX
@article{Bashier2023,
  author = {Bashier, Alaaeldin and Farghaly, Mohamed and Alali, Juwairia Yousif and AlHadari, Amna Khalifa and Ajaz, Yasmin and Warrier, Vani Krishna and Abdelgadir, Elamin and Farooqi, Muhammad Hamed and Qamar, Sana and Alsayed, Mohamed and Fahmy, Mohamed Samir and Tannouri, Dali and Gowda, Arun Jayarame and Awad, Nancy Syed and Ramachandrachar, Badarinath Chickballapur and Natarajan, Ashok},
  title = {Real-World Evaluation of Demographics, Treatment Pattern, and Economic Burden of Heart Failure and Kidney Disease in Type 2 Diabetes Mellitus Patient Population in Dubai, United Arab Emirates},
  journal = {Dubai Diabetes and Endocrinology Journal},
  year = {2023},
  volume = {29},
  number = {1},
  pages = {42--54},
  doi = {10.1159/000530467}
}
Kostenlos starten →